Capital Meets Conviction: VENU, HSDT, GLUE, and IHT Show Investors the Money
DENVER, Colo., Sep 15, 2025 (247marketnews.com)- VENU (NYSE:VENU) took center stage this morning, announcing a multi-year exclusive ticketing and commerce partnership with Tixr, which also made a strategic equity investment in the live entertainment venue operator. Tixr will power all current and future VENU locations, including sites in Colorado Springs, Centennial, Gainesville, and an undisclosed market, aligning both companies with shared upside in ticketing, fan experience, and venue marketing.
Tixr’s purchase of 62,500 shares of VENU stock in a private placement reinforces the commitment and long-term strategic value of the partnership. Combined with an earlier stake from Aramark (NYSE:ARMK), this marks a rare dual endorsement from two major service partners, suggesting confidence in VENU’s scalable premium venue model.
Helius Medical Technologies (NASDAQ:HSDT) surged in early buzz after revealing a $500M+ private investment led by Pantera Capital and Summer Capital to fund SOL Treasury Company, a pioneering crypto treasury strategy that will use Solana (SOL) as its primary reserve asset. The company plans to purchase and stake SOL to earn yield, unlocking value via decentralized finance. The deal could reach $1.25 billion in value with full warrant exercise.
Incoming leaders from UBS, Pantera, and other crypto-native firms are expected to steer HSDT through a transformation into a Solana-aligned public vehicle, potentially capturing the same strategic advantage that fueled MicroStrategy’s BTC strategy.
Monte Rosa Therapeutics (NASDAQ:GLUE) rose premarket on news of a $120 million upfront licensing deal with Novartis (NYSE:NVS). The collaboration gives Novartis rights to Monte Rosa’s degraders targeting immune-mediated diseases, with potential for significant milestone payments and royalties. The deal builds on their existing VAV1 partnership and extends Monte Rosa’s cash runway through key Phase 2 clinical readouts.
The partnership highlights the growing value of Monte Rosa’s QuEEN AI/ML drug discovery engine, reinforcing investor confidence in its emerging immunology pipeline.
InnSuites Hospitality Trust (NYSE:IHT) posted solid $4 million in revenue for the first half of fiscal 2026 and continues its diversification into boutique hotel branding via a revitalized IBC Hotels platform. August’s hotel revenue of $547,571 set a monthly record. IHT also reaffirmed its semi-annual dividend streak, now 55 years running.
Additionally, IHT’s clean energy diversification through a stake in UniGen Power positions it for potential long-term upside in next-gen electricity markets.
NanoVibronix (NASDAQ:NAOV) added to its IP arsenal with a newly granted U.S. patent for ENvue Medical, its medical navigation subsidiary. The patent, titled “Insertion Device Positioning Guidance System and Method,” bolsters ENvue’s electromagnetic technology for device placement, improving safety and precision in enteral procedures. The move supports NanoVibronix’s broader strategy to secure technological defensibility in a niche, high-stakes medical segment.
Please click here to read Cenorium’s full Venu analyst report on 247marketnews.com.
For the full 24/7 Market News VENU report and in-depth insights, visit: Read 24/7 Market News VENU Report/
Contact sales@247marketnews.com for Analyst Report coverage and other investor/public relations services.
24/7 MARKET NEWS, INC (247) Disclaimer and Disclosure
PAID EDITORIAL DISCLOSURE: 247MarketNews.com has been compensated $2,500 per week by MicroCap Strategies for ongoing press and editorial coverage of VENU. This is a paid editorial communication intended for informational purposes only. Please review 247’s Full Disclaimer https://www.247marketnews.com/disclaimer/. This press release may include technical analysis for informational purposes only and should not be construed as financial or investment advice. Trading stocks involves risks, and readers should consult with their financial advisor before making investment decisions. Please go to https://247marketnews.com/venu-disclosure/ for additional 247marketnews.com VENU disclosure information.
About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.
24/7 MARKET NEWS, INC Disclaimer
Please go to https://247marketnews.com/disclaimer/ for disclaimer information.
CONTACT:
24/7 Market News
Editor@247marketnews.com